bone marrow failure syndromes
Showing 1 - 25 of >10,000
Cancer in Inherited Bone Marrow Failure Syndromes
Recruiting
- Diamond Blackfan Anemia
- +4 more
-
Bethesda, Maryland
- +1 more
Jan 24, 2023
Acquired and Inherited Bone Marrow Failure Syndromes
Recruiting
- Severe Aplastic Anemia
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 12, 2022
Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,
Recruiting
- Primary Immune Deficiency Disorder
- +2 more
- Alemtuzumab
- +6 more
-
Baltimore, MarylandJohns Hopkins University
Oct 20, 2022
Mutations and Phenotypes of Unclassifiable Inherited Bone Marrow
Recruiting
- Inherited BMF Syndrome
- The whole-exome sequencing
-
Sohag, Egypt, Faculty of Medicine, Sohag University
Jun 28, 2022
Bone Marrow Failure Syndromes Trial in Philadelphia (MRD-BMT with Fludarabine-based RIC for Acquired AA, MRD-BMT with
Recruiting
- Bone Marrow Failure Syndromes
- MRD-BMT with Fludarabine-based RIC for Acquired AA
- +2 more
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
May 6, 2022
Inherited Bone Marrow Failure Syndrome, Familial Platelet Disorder With Predisposition to Myeloid Malignancies Trial run by the
Not yet recruiting
- Inherited Bone Marrow Failure Syndrome
- Familial Platelet Disorder With Predisposition to Myeloid Malignancies
- imatinib
- TruSight Oncology
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 20, 2023
Severe Aplastic Anemia, MDS (Myelodysplastic Syndrome) Trial in Baltimore, Bethesda, Minneapolis (Miltenyi CD34 Reagent System,
Recruiting
- Severe Aplastic Anemia
- MDS (Myelodysplastic Syndrome)
- Miltenyi CD34 Reagent System
- Donor derived G-CSF mobilized PBC
-
Baltimore, Maryland
- +2 more
Jan 25, 2023
Squamous Cell Carcinoma in Fanconi Anemia
Recruiting
- Fanconi Anemia
- Inherited Bone Marrow Failure Syndrome
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Acquired Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, Inherited Bone Marrow Failure Syndromes Trial in Philadelphia
Recruiting
- Acquired Aplastic Anemia
- +2 more
- CliniMACs
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Mar 1, 2022
Using Genomics in Inherited Bone Marrow Failure (IBMDx Study)
Recruiting
- Inherited BMF Syndrome
- +2 more
- whole genome and transcriptome sequencing
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
Mar 28, 2022
Acute Myeloid Leukemia, MDS, Myeloid Malignancies Trial in Boston (Decitabine, Filgrastim)
Not yet recruiting
- Acute Myeloid Leukemia
- +6 more
-
Boston, Massachusetts
- +1 more
Mar 31, 2023
Severe Aplastic Anemia, Bone Marrow Failure Syndromes Trial in Baltimore, Milwaukee (procedure, drug, radiation)
Completed
- Severe Aplastic Anemia
- Bone Marrow Failure Syndromes
- Bone marrow transplant
- +7 more
-
Baltimore, Maryland
- +1 more
Feb 10, 2022
Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
Recruiting
- Primary Immunodeficiency (PID)
- +4 more
- data collection
-
Pittsburgh, PennsylvaniaUPMC Children's Hospital of Pittsburgh
Feb 9, 2022
Severe Sickle Cell Disease, Bone Marrow Failure Syndromes, Metabolic Disorders Trial in New Haven, Saint Louis (RIC regimen,
Recruiting
- Severe Sickle Cell Disease
- +5 more
- RIC regimen
- GVHD prophylaxis regimen
-
New Haven, Connecticut
- +1 more
Feb 4, 2022
Leukemia, Inborn Errors of Metabolism, Bone Marrow Failure Syndromes Trial in Philadelphia (Transplant of stem cells with
Recruiting
- Leukemia
- +4 more
- Transplant of stem cells with CD3+/CD19+ depletion (CliniMACs)
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Nov 2, 2021
Malignant Diseases (ie, Leukemia, MDS, Lymphoma), Non-malignant Diseases (ie, Bone Marrow Failure Syndromes) Trial in Milwaukee
Completed
- Malignant Diseases (ie, Leukemia, MDS, Lymphoma)
- Non-malignant Diseases (ie, Bone Marrow Failure Syndromes)
- CliniMACS (CD+3, CD+19 depletion)
- +2 more
-
Milwaukee, WisconsinChildren's Hospital of Wisconsin
Oct 21, 2021
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, MDS Trial in Houston (CliniMACS)
Not yet recruiting
- Acute Lymphoblastic Leukemia in Remission
- +10 more
- CliniMACS
-
Houston, Texas
- +1 more
Dec 8, 2022
Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with
Recruiting
- Acute Leukemia
- +27 more
- HSCT with TBI Regimen
- HSCT with Non-TBI Regimen
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Apr 12, 2022
Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Acute Myeloid Leukaemia Trial in United Kingdom (Reduced intensity haplodentical
Active, not recruiting
- Hodgkin's Lymphoma
- +8 more
- Reduced intensity haplodentical stem cell transplant
- Myeloablative haploidentical stem cell transplant
-
Birmingham, United Kingdom
- +11 more
Sep 27, 2021
Myelodysplastic Syndrome, Recurrent Myelodysplastic Syndrome, Refractory Myelodysplastic Syndrome Trial in Philadelphia
Recruiting
- Myelodysplastic Syndrome
- +2 more
- Navitoclax
- +6 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Feb 2, 2023
Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia/Lymphoma Trial in Minneapolis (drug, radiation, biological)
Recruiting
- Acute Leukemia
- +24 more
- Fludarabine
- +6 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Nov 4, 2021
Bone Marrow Failure Disorders, Aplastic Anemia, Thrombocytopenia Trial in Iowa City (Romiplostim)
Recruiting
- Bone Marrow Failure Disorders
- +4 more
-
Iowa City, IowaUniversity of Iowa Hospitals & Clinics
Jun 4, 2021
Severe Aplastic Anemia, Single Lineage Cytopenias, T-LGL, Hypoplastic MDS Trial run by the National Heart, Lung, and Blood
Not yet recruiting
- Severe Aplastic Anemia
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 23, 2023
Bone Marrow Disease Trial in Santa Monica, Houston (CK0801)
Active, not recruiting
- Bone Marrow Disease
- CK0801
-
Santa Monica, California
- +1 more
Jan 3, 2023
Primary Immunodeficiencies, Inborn Errors of Metabolism, Haemoglobinopathies Trial in Worldwide (Treosulfan, Busilvex)
Active, not recruiting
- Primary Immunodeficiencies
- +3 more
-
Prague, Czechia
- +20 more
Apr 19, 2022